253 Shares in iShares Biotechnology ETF (NASDAQ:IBB) Bought by CX Institutional

CX Institutional bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the 1st quarter, according to its most recent disclosure with the SEC. The fund bought 253 shares of the financial services provider’s stock, valued at approximately $32,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Proficio Capital Partners LLC acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter valued at about $480,000. IFP Advisors Inc lifted its stake in iShares Biotechnology ETF by 237.1% in the fourth quarter. IFP Advisors Inc now owns 16,018 shares of the financial services provider’s stock valued at $2,118,000 after buying an additional 11,266 shares during the period. FineMark National Bank & Trust bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $319,000. Destiny Wealth Partners LLC grew its position in shares of iShares Biotechnology ETF by 6.7% during the 1st quarter. Destiny Wealth Partners LLC now owns 69,865 shares of the financial services provider’s stock worth $8,936,000 after buying an additional 4,358 shares during the period. Finally, Cullen Frost Bankers Inc. increased its stake in shares of iShares Biotechnology ETF by 1.5% in the 4th quarter. Cullen Frost Bankers Inc. now owns 5,654 shares of the financial services provider’s stock valued at $748,000 after acquiring an additional 82 shares in the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 2.0%

iShares Biotechnology ETF stock opened at $125.32 on Wednesday. iShares Biotechnology ETF has a 12-month low of $107.43 and a 12-month high of $150.57. The firm’s fifty day moving average is $122.40 and its 200 day moving average is $130.20.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.